Stuttgart – Atlas Copco AB, a leading provider of sustainable productivity solutions with revenues of EUR 9 billion in 2017, has agreed to acquire the cryogenic business of Brooks Automation, Inc., for a total value of USD 675 million. The acquisition includes cryo pump operations located in Chelmsford, USA, and Monterrey, Mexico, a worldwide network of sales and service centers, and Brooks Automation's 50% share of Ulvac Cryogenics, Inc., (UCI). The acquisition is an all-cash transaction utilizing Atlas Copco's existing funds and is subject to regulatory approvals. The acquisition complements Atlas Copco's existing technology portfolio with a new range of high vacuum pumps that optimize the removal of water vapour and hydrogen, which is critical to many semiconductor and industrial processes.
A CMS team headed by Dr Christian Haellmigk is advising Atlas Copco on all aspects of competition law. Haellmigk has advised the Swedish group in many other cases, including the 2014 acquisition of Edwards Group Ltd., the 2016 acquisition of Oerlikon Leybold Vacuum and the 2017 divestiture of Atlas Copco's Road Construction Equipment division.
Atlas Copco is based in Stockholm, Sweden and has a global reach spanning more than 180 countries. With about 34,000 employees worldwide the Group offers products and services that range from compressors, vacuum solutions, generators, pumps, power tools and assembly systems.
The cryogenic business of Brooks Automation, Inc., which is headquartered in Chelmsford, Massachusetts, USA, has about 400 employees and revenues of approximately USD 195 million in the last 12 months. The revenue for the joint venture is not included in this figure. UCI is a joint venture with Ulvac, Inc., a company listed on the Tokyo stock exchange. UCI had total revenues of approximately USD 100 million in the fiscal year ending June 2017.
Dr Christian Friedrich Haellmigk, Lead Partner
Dr Rolf Hempel, Partner
Cosima Gräfin von Rechteren, Counsel
Martin Cholewa, Senior Associate
Malena Hansen, Associate, all Competition & EU